BioSpace News Archive

Albany NY, United States: In biological research procedures, there is frequent utilization of molecular labels that are linked to a protein of interest in order to assist in the detection as well as purification of the labeled protein along with its binding partners.

The rising incidence of venous leg ulcers has emerged as a serious clinical problem worldwide, draining substantial financial resources.

Positive results from the Phase 1/2 dose-finding study evaluating the safety, pharmacokinetics and clinical activity of rilzabrutinib, an investigational oral Bruton’s tyrosine kinase inhibitor, in adults with heavily pre-treated immune thrombocytopenia were published in the New England Journal of Medicine.

Emergex Vaccines Holding Limited announces that it is progressing preclinical development of its intracellular bacterial vaccine candidate for Francisellatularensis following the completion of successful ligandome generation.

Akeso, Inc. announced the publication of preclinical results of its PD-1/CD73 bi-specific antibody at the American Association for Cancer Research Annual Meeting 2022.

The shareholders of Calliditas Therapeutics AB, Reg. No. 556659-9766, with registered office in Stockholm, are summoned to the annual general meeting on Thursday 19 May 2022.

Evelo Biosciences, Inc. provided an update on the progress of its lead program in inflammation, EDP1815, and announced it will put the EDP1867 program on hold following completion of a Phase 1 clinical trial.

West Pharmaceutical Services, Inc. announced that it will release first-quarter 2022 financial results before the market opens on Thursday, April 28, 2022, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

Alzheon, Inc. announced that it has completed an oversubscribed $50 million Series D round from private and institutional investors.

Alzheon, Inc. announced the appointments of Susan Flint as Vice President of Clinical Operations, Patrick Kesslak, PhD, as Vice President of Clinical Development & Medical Affairs, and Erwan de Naurois as Vice President of Finance.